Monitoring-Based Model for Personalizing Fecal Incontinence in Patients With Crohn's Disease: A Multicenter Inception Cohort Study

被引:0
|
作者
Wang, Can [1 ]
Yang, Fan [2 ]
Qiao, Lichao [1 ]
Wang, Xiaoxiao [3 ]
Chen, Qi [1 ]
Chen, Hongjin [1 ]
Li, Yi [4 ]
Zhang, Xiaoqi [5 ]
Liao, Xiujun [6 ]
Cao, Lei [4 ,7 ]
Xu, Haixia [1 ]
Xiang, Yu [1 ]
Yang, Bolin [1 ]
机构
[1] Nanjing Univ Chinese Med, Jiangsu Prov Hosp Chinese Med, Affiliated Hosp, Dept Colorectal Surg, 155 Han Zhong Rd, Nanjing, Peoples R China
[2] Univ New South Wales, Sch Math & Stat, Dept Sci, Sydney, Australia
[3] Nanjing Univ Chinese Med, Affiliated Hosp, Jiangsu Prov Hosp Chinese Med, Dept GCP Res Ctr, Nanjing, Peoples R China
[4] Nanjing Univ, Jinling Hosp, Med Sch, Dept Gen Surg, Nanjing, Peoples R China
[5] Nanjing Univ Med Sch, Nanjing Drum Tower Hosp, Affiliated Hosp, Dept Gastroenterol, Nanjing, Peoples R China
[6] Zhejiang Univ, Affiliated Hosp 2, Sch Med, Key Lab Canc Prevent,Minist Educ,Dept Colorectal S, Hangzhou, Peoples R China
[7] Nanjing Univ Tradit Chinese Med, Nanjing Hosp, Hosp Nanjing 2, Dept Gastroenterol, Nanjing, Peoples R China
关键词
Crohn's disease; fecal incontinence; risk factor; nomogram; INFLAMMATORY-BOWEL-DISEASE; PERIANAL FISTULAS; MANAGEMENT; CONSENSUS; OUTCOMES; SYMPTOM; URGENCY; BURDEN; OLDER;
D O I
10.1093/ibd/izae006
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background and Aims: Fecal incontinence (FI) is a common complaint that greatly affects the quality of life of patients with Crohn's disease (CD) and is associated with the clinical characteristics of CD. We aimed to identify risk factors related to FI and construct a risk prediction model for FI in patients with CD. Methods: This retrospective study included 600 Chinese patients with CD from 4 IBD centers between June 2016 and October 2021. The patients were assigned to the training (n = 480) and testing cohorts (n = 120). Two nomograms were developed based on the logistic regression and Cox regression models to predict the risk factors for FI in patients with CD. The discriminatory ability and accuracy of the nomograms were evaluated using the receiver operating characteristic (ROC) curves and the area under the ROC curves (AUCs). Additionally, the Kaplan-Meier survival curve was also used further to validate the clinical efficacy of the Cox regression model. Results: The overall prevalence of FI was 22.3% (n = 134 of 600). In the logistic regression model, age at diagnosis (odds ratio [OR], 1.032; P = .033), penetrating behavior of disease (OR, 3.529; P = .008) and Perianal Disease Activity Index score >4 (OR, 3.068; P < .001) were independent risk factors for FI. In the Cox regression model, age at diagnosis (hazard ratio [HR], 1.027; P = .018), Montreal P classification (HR, 2.608; P = .011), and Perianal Disease Activity Index score >4 (HR, 2.190; P = .001) were independent predictors of the prevalence of FI over time. Two nomograms were developed to facilitate risk score calculation, and they showed good discrimination ability according to AUCs. Conclusions: In this study, we identified 4 risk factors related to the prevalence of FI and developed 2 models to effectively predict the risk scores of FI in CD patients, helping to delay the course of FI and improve the prognosis with timely intervention.
引用
收藏
页码:2314 / 2322
页数:9
相关论文
共 50 条
  • [11] Vedolizumab for perianal Crohn's disease: a multicentre cohort study in 151 patients
    Chapuis-Biron, Constance
    Bourrier, Anne
    Nachury, Maria
    Nancey, Stephane
    Bouhnik, Yoram
    Serrero, Melanie
    Armengol-Debeir, Laura
    Buisson, Anthony
    Tran-Minh, My-Linh
    Zallot, Camille
    Fumery, Mathurin
    Bouguen, Guillaume
    Abitbol, Vered
    Viennot, Stephanie
    Chanteloup, Elise
    Rajca, Sylvie
    Dib, Nina
    Parmentier, Anne-Laure
    Peyrin-Biroulet, Laurent
    Vuitton, Lucine
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 51 (07) : 719 - 727
  • [12] Characteristics of adult patients newly diagnosed with Crohn's disease: interim analysis of the nation-wide inception cohort registry study of patients with Crohn's disease in Japan (iCREST-CD)
    Matsuoka, Katsuyoshi
    Fujii, Toshimitsu
    Okamoto, Ryuichi
    Yamada, Akihiro
    Kunisaki, Reiko
    Matsuura, Minoru
    Watanabe, Kenji
    Shiga, Hisashi
    Takatsu, Noritaka
    Bamba, Shigeki
    Mikami, Yohei
    Yamamoto, Takayuki
    Shimoyama, Takahiro
    Motoya, Satoshi
    Torisu, Takehiro
    Kobayashi, Taku
    Ohmiya, Naoki
    Saruta, Masayuki
    Matsuda, Koichiro
    Matsumoto, Takayuki
    Nakase, Hiroshi
    Maemoto, Atsuo
    Shinzaki, Shinichiro
    Murata, Yoko
    Yoshigoe, Shinichi
    Sasaki, Ayako
    Yajima, Tsutomu
    Hisamatsu, Tadakazu
    JOURNAL OF GASTROENTEROLOGY, 2022, 57 (11) : 867 - 878
  • [13] Prevalence and predictors of hospitalization in Crohn's disease in a prospective population-based inception cohort from 2000-2012
    Golovics, Petra A.
    Lakatos, Laszlo
    Mandel, Michael D.
    Lovasz, Barbara D.
    Vegh, Zsuzsanna
    Kurti, Zsuzsanna
    Szita, Istvan
    Kiss, Lajos S.
    Pandur, Tunde
    Lakatos, Peter L.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (23) : 7272 - 7280
  • [14] Comparison between Pediatric Crohn's Disease and Ulcerative Colitis at Diagnosis in Korea: Results from a Multicenter, Registry-Based, Inception Cohort Study
    Park, Sowon
    Kang, Ben
    Kim, Seung
    Choi, Sujin
    Suh, Hyo Rim
    Kim, Eun Sil
    Park, Ji Hyung
    Kim, Mi Jin
    Choe, Yon Ho
    Lee, Yeoun Joo
    Park, Jae Hong
    Ryoo, Eell
    Koh, Hong
    Choe, Byung-Ho
    GUT AND LIVER, 2022, 16 (06) : 921 - 929
  • [15] Mesh Repair in Crohn's Disease: A Case-Matched Multicenter Study in 234 Patients
    Beyer-Berjot, Laura
    Moszkowicz, David
    Bridoux, Valerie
    Schneider, Lucil
    Theuil, Luca
    Francois, Yves
    Abdalla, Solafah
    Cotte, Eddy
    Maggiori, Leon
    Brouquet, Antoine
    Souche, Francois-Regis
    Zerbib, Philippe
    Tuech, Jean-Jacques
    Panis, Yves
    Berdah, Stephane
    WORLD JOURNAL OF SURGERY, 2020, 44 (07) : 2394 - 2400
  • [16] Effectiveness and Tolerability of Methotrexate Combined with Biologics in Patients with Crohn's Disease: A Multicenter Observational Study
    Park, Jihye
    Chun, Jaeyoung
    Park, Soo Jung
    Park, Jae Jun
    Kim, Tae Il
    Yoon, Hyuk
    Cheon, Jae Hee
    DIGESTIVE DISEASES AND SCIENCES, 2024, 69 (03) : 901 - 910
  • [17] Combination of serological biomarkers and clinical features to predict mucosal healing in Crohn's disease: a multicenter cohort study
    Tang, Nana
    Chen, Han
    Chen, Ruidong
    Tang, Wen
    Zhang, Hongjie
    BMC GASTROENTEROLOGY, 2022, 22 (01)
  • [18] Patient experiences with and adherence to Crohn's disease exclusion diet in Dutch Crohn's disease patients: a cohort study
    Wijers, Fleur T. R.
    van Zundert, Suzanne M. C.
    Verburgt, Charlotte M.
    van der Kruk, Nikki
    Van Limbergen, Johan E.
    Wierdsma, Nicolette J.
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2025, 18
  • [19] Association of diagnostic delay with medical cost for patients with Crohn's disease: A Japanese claims-based cohort study
    Takeyama, Eisuke
    Wada, Hiroo
    Sato, Setsuko
    Tomooka, Kiyohide
    Ikeda, Ai
    Tanigawa, Takeshi
    JGH OPEN, 2021, 5 (05): : 568 - 572
  • [20] Early Surgical Resection in Pediatric Patients with Localized Ileo-Cecal Crohn's Disease: Results of a Retrospective Multicenter Study
    Madaffari, Isabella
    Muttillo, Edoardo Maria
    Franca, Alice La
    Massimi, Fanny
    Castagnola, Giorgio
    Coppola, Alessandro
    Furio, Silvia
    Piccirillo, Marisa
    Ferretti, Alessandro
    Mennini, Maurizio
    Parisi, Pasquale
    Cozzi, Denis A.
    Ceccanti, Silvia
    Felici, Enrico
    Alessio, Pini Prato
    Lisi, Gabriele
    Illiceto, Maria Teresa
    Sperduti, Isabella
    Di Nardo, Giovanni
    Mercantini, Paolo
    JOURNAL OF CLINICAL MEDICINE, 2025, 14 (02)